Integrin Antagonists 27 structure
|
Common Name | Integrin Antagonists 27 | ||
|---|---|---|---|---|
| CAS Number | 593274-97-6 | Molecular Weight | 444.44 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H20N4O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Integrin Antagonists 27Integrin Antagonists 27 is a small molecule integrin αvβ3 antagonist with binding affinity of 18 nM, as s novel anticancer agent. Target: Integrinin vitro: Integrin Antagonists 27 is treated with a panel of cancer cell-lines (breast cancer cell line MDA-MB-435, breast cancer cell lines MCF-7, mouse fibroblast NIH3T3, ovarian cancer cell line HEY, lung cancer cell line NCI-H1975) with all IC50 of >20 uM. |
| Name | Integrin Antagonists 27 |
|---|
| Description | Integrin Antagonists 27 is a small molecule integrin αvβ3 antagonist with binding affinity of 18 nM, as s novel anticancer agent. Target: Integrinin vitro: Integrin Antagonists 27 is treated with a panel of cancer cell-lines (breast cancer cell line MDA-MB-435, breast cancer cell lines MCF-7, mouse fibroblast NIH3T3, ovarian cancer cell line HEY, lung cancer cell line NCI-H1975) with all IC50 of >20 uM. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C24H20N4O5 |
|---|---|
| Molecular Weight | 444.44 |
| Storage condition | 2-8℃ |